Revolutionary caregiver engagement solution merges recruitment, AI, scheduling, and rewards into a single powerful platform CareConnect LLC, the leader in AI-driven caregiver recruitment and scheduling, today announced the launch of CareConnect Engage, powered by CoachUp Care. Launched in partnership with MissionCare Collective, the parent company behind myCNAjobs and CoachUp Care, the platform delivers a transformative […]

The Board of Trustees of each of the Invesco closed-end funds listed below declared dividends. https://mma.prnewswire.com/media/1434026/Invesco_Logo.jpg EX-DATE RECORD DATE REINVEST DATE PAYABLE DATE7/16/2025 7/16/2025 7/31/2025 7/31/2025Name of Closed-End Ticker Monthly Dividend Change From Prior Distribution % Change From Prior DistributionManagement Investment Company Per ShareInvesco Advantage Municipal Income Trust II VKI $0.05591 – -Invesco Bond Fund

Builds North America's Largest Tech-Driven Parking, Transportation, and Mobility Company LAZ Parkingannounced today the completion of an acquisition that gives it a 60% majority stake in INDIGO Park Canada Inc. (IPC), creating North America's largest tech-driven parking, transportation, and mobility company. https://mma.prnewswire.com/media/844952/LAZ_Parking_Logo.jpg The acquisition reunites LAZ with the INDIGO Group, building on their successful partnership

Medcrypt's Guardian PKI and Cryptography Platform integrates intoC2A Security's Product Security Orchestration Platform to provide end-to-end product security and compliance to medical device manufacturers C2A Security, the only context-driven product security orchestration platform that addresses the specific needs of software-defined products and cyber-physical systems, and Medcrypt, the leading provider of proactive cybersecurity solutions for medical

EKINOPS(Euronext Paris – FR0011466069 – EKI), a leading supplier of optical transport, branch routing and SASE solutions, announces that ecotel, one of the leading German telecommunications service providers for cloud and broadband services has successfully deployed a virtualized network for Volkswagen Group Retail Deutschland (VGRD GmbH), Germany's largest automobile trading group. https://mma.prnewswire.com/media/2722740/Ekinops_ecote.jpg VGRD GmbH was

The ColoradoRockies and York Space Systems (York), a Denver-based leader in aerospace and defense technology, today announced a historic jersey patch partnership beginning July 1, 2025, and continuing through the 2030 MLB season. https://mma.prnewswire.com/media/2722520/YorkRockiesLogo1_Logo.jpg With this announcement, York becomes the first aerospace company in history to partner on a jersey patch deal across any professional

Behring Co., a San Francisco Bay Area real estate developer and the operator of Behring Regional Center, is proud to announce USCIS approved the Form I-956F of its latest EB-5 infrastructure project: the Community Investment for Veterans' Infrastructure and Care (“CIVIC”) Project. USCIS's I-956F approval confirms that CIVIC qualifies as an infrastructure project, providing EB-5

Elior North America Consolidates and Rebrands Education-Focused Dining Divisions to Better Serve Students at Every Level Elior North America, a leading foodservice provider with a strong presence across the education sector, announced today a comprehensive rebrand of its education-focused dining divisions. The transformation includes the renaming and repositioning of Aladdin Campus Dining, Lexington Independents, Cater

University Lab Partners (ULP) is proud to announce the winners of the inaugural I-CREATE Showcase where nine groundbreaking MedTech startups pitched their innovations to a distinguished panel of investors, industry experts, and public health leaders. https://mma.prnewswire.com/media/2721302/ICreate_ULP_Side_02.jpg Taking top honors were: — $50,000 Prize – Acorn Genetics — $30,000 Prize – Latde Diagnostics — $20,000 Prize

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and Ramsay Hospital Research Foundation Precision medicine approach: The 60-patient Phase 2 study uses the PCPro™ lipid biomarker test to identify patients with poor prognosis most likely to benefit from the combination